Showing results 6 to 8 of 8
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Metabolic dysfunction-associated steatotic liver disease is a risk factor for lower vaccine immunogenicity against SARS-COV-2 omicron variant among three-dose BNT162b2 recipients Proceeding/Conference:Medical Research Conference, the University of Hong Kong (20/01/2024-20/01/2024, , , Hong Kong) | 20-Jan-2024 | |||
Sodium-glucose cotransporter-2 inhibitors associated with lower risk of hepatocellular carcinoma and hepatic decompensation in type 2 diabetes mellitus Proceeding/Conference:Digestive Disease Week 2024 (18/05/2024-21/05/2024, , , Washington, DC, USA) | 18-May-2024 | |||
Vonoprazan-based dual and triple therapy versus bismuth-based quadruple therapy as first-line therapy for Helicobacter pylori in China: a three-arm, randomized clinical trial Proceeding/Conference:Digestive Disease Week 2024 (18/05/2024-21/05/2024, , , Washington, DC, USA) | 18-May-2024 |